BASEL, January 19, 2024: Epista Life Science announced today the launch of their Manufacturing Operations offerings, extending their already strong end-to-end portfolio of advisory and consulting services. This expansion arrives hand in hand with the latest step in Epista’s journey towards global growth: a new subsidiary in Basel, Switzerland opening February 1st, 2024.
“Our expansion into Switzerland, marks a pivotal moment for our company as we aim to expand our central European footprint. This strategic move aligns with our commitment to growth, pairing our Life Science focus with one of the largest pharmaceutical hubs in the world. This will be a groundbreaking expansion which will support Epista’s international growth,” states Flemming Kjoeller, SVP and Chief Growth Officer in the company.
Epista Life Science’s presence in Switzerland will bring decades of industry subject matter expertise to one of the Life Science industry’s most important hubs. With more than 700 Life Science companies conducting business in Basel alone, there is unparalleled opportunity to pioneer and make an impact with both Epista’s existing portfolio and its new Manufacturing Operations services.
By expanding its services with Manufacturing Operations, Epista will provide a turn-key portfolio that will enable Life Science companies to embrace the digitalization of manufacturing and quality and integrate it across the supply chain. These abilities are based on many years and a variety of experience across the Life Science industry and can include:
Klavs Esbjerg, CEO, says, “We have been working with manufacturing and automation since 2014 and by extending this with Manufacturing Operations services, we have the chance to help our clients achieve operational excellence. Epista's long term goal is to build a global services platform for Life Science, so kicking this off in Switzerland not only gives us an important foothold in a key industry hub, but also brings us one step closer to completing our vision and helping Life Science companies bring their health care innovations to society.”
This exciting expansion of regional capabilities and services is possible due to the addition of Hernan Vilas as SVP and Head of Manufacturing Operations who also reflected on his choice to join the team. “I am happy to join Epista and use my extensive Life Science background to help empower companies of all sizes in embracing digital transformation as well as accelerate their path to delivering innovative medicines to patients. With over 20 years of experience working for leading companies like Roche and Lonza, I am committed to fostering a culture of digital excellence in addition to developing the most talented professionals. Together, we will empower our customers to harness the power of digital technologies, optimize their operations, enhance quality, and drive sustainable growth."
Learn more about Epista Life Science at www.epista.com
_______________________________________________________
About Epista Life Science (“Epista”)
Epista, founded in 2009, is a Life Science-focused digital services and consultancy firm assisting companies worldwide. They are headquartered in Denmark and have subsidiaries in Sweden, Germany, and Switzerland. The company works at the intersection of business and compliance to anticipate the impacts that changing technology and regulatory requirements will have on the industry. By implementing technologies and pioneering methodologies, Epista helps their clients adapt while also increasing their performance. In this way, they help the industry drive the innovations that improve health care around the world.
For more information, please contact Epista Life Science:
Flemming Kjoeller, SVP & Chief Growth Officer
We enjoy sharing our knowledge. Get in touch to find out how Epista can add value to your Life Science company.
.png)
